Focus on the ONTARGET results

Henry L Elliott1

  • 1Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK. henrylelliott@aol.com

Insights

Telmisartan and ramipril demonstrated equivalent cardiovascular protection in high-risk patients. Telmisartan showed better tolerability, with fewer discontinuations, making it a strong option for renin-angiotensin system blockade.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Renin-angiotensin system (RAS) blockade is crucial for managing patients with high cardiovascular risk.
  • Ramipril is a widely accepted 'reference' drug for RAS blockade.

Purpose of the Study:

  • To compare the cardiovascular protection of telmisartan versus ramipril in high-risk patients.
  • To evaluate the overall efficacy and tolerability of telmisartan compared to ramipril.

Main Methods:

  • The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) involved 23,400 high-risk cardiovascular patients.
  • Direct comparison of telmisartan and ramipril effectiveness and tolerability.

Main Results:

  • Telmisartan and ramipril were found to be therapeutically equivalent in providing cardiovascular protection.
  • Telmisartan exhibited a superior overall efficacy/tolerability ratio due to fewer patient discontinuations.

Conclusions:

  • Telmisartan is the only angiotensin II blocker with demonstrated cardiovascular protection equivalent to ramipril.
  • Telmisartan offers a favorable efficacy and tolerability profile for RAS blockade in high-risk individuals.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Methods of Documentation IV: Focus Charting01:26

Methods of Documentation IV: Focus Charting

Focus Charting, also known as the focus charting system or "focus documentation," is a systematic documentation approach used in healthcare to organize patient information in medical records.
It typically involves three columns for recording information:
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...